Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNS
2151
DELISTED
Avanos Medical
AVNS
| $2.14M | ﹤0.01% |
+72,800
| New | +$2.11M |
|
2152
CareCloud
CCLD
$110M
| $2.13M | ﹤0.01% |
257,208
+211,175
| +459% | +$1.43M |
|
2153
Chemung Financial Corp
CHMG
$405M
| $2.13M | ﹤0.01% |
78,088
-1,600
| -2% | -$42.2K |
|
|
AVID
2154
DELISTED
Avid Technology Inc
AVID
| $2.13M | ﹤0.01% |
292,367
-593,089
| -67% | -$3.91M |
|
|
HNP
2155
DELISTED
Huaneng Power Intl, Inc.
HNP
| $2.13M | ﹤0.01% |
140,700
+5,500
| +4% | +$80.5K |
|
2156
Urban One Class A
UONE
$23.3M
| $2.12M | ﹤0.01% |
10,490
+1,120
| +12% | +$59K |
|
2157
Option Care Health
OPCH
$3.59B
| $2.12M | ﹤0.01% |
152,976
-118,780
| -44% | -$1.57M |
|
2158
PENN Entertainment
PENN
$2.52B
| $2.12M | ﹤0.01% |
69,500
-645,302
| -90% | -$14.8M |
|
|
SAFE
2159
Safehold
SAFE
$1.08B
| $2.12M | ﹤0.01% |
35,377
-87,756
| -71% | -$4.42M |
|
2160
State Street Materials Select Sector SPDR ETF
XLB
$8.6B
| $2.11M | ﹤0.01% |
+74,800
| New | +$1.97M |
|
2161
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $2.1M | ﹤0.01% |
26,600
+16,000
| +151% | +$1.16M |
|
2162
Global Ship Lease
GSL
$1.52B
| $2.1M | ﹤0.01% |
495,746
-17,504
| -3% | -$74.8K |
|
2163
State Street SPDR S&P Homebuilders ETF
XHB
$1.59B
| $2.1M | ﹤0.01% |
+47,868
| New | +$1.82M |
|
|
YRD
2164
Yiren Digital
YRD
$104M
| $2.1M | ﹤0.01% |
508,365
-15,800
| -3% | -$62.8K |
|
2165
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $2.1M | ﹤0.01% |
+15,600
| New | +$2.03M |
|
2166
Pitney Bowes
PBI
$2.25B
| $2.09M | ﹤0.01% |
805,500
+2,606
| +0.3% | +$6.51K |
|
2167
Lantronix
LTRX
$289M
| $2.09M | ﹤0.01% |
563,564
-88,500
| -14% | -$276K |
|
|
RNWK
2168
DELISTED
RealNetworks Inc
RNWK
| $2.08M | ﹤0.01% |
1,603,048
+268,986
| +20% | +$295K |
|
2169
Plexus
PLXS
$7.13B
| $2.08M | ﹤0.01% |
29,493
-2,600
| -8% | -$161K |
|
2170
RGC Resources
RGCO
$224M
| $2.05M | ﹤0.01% |
84,895
+21,995
| +35% | +$559K |
|
2171
Escalade
ESCA
$276M
| $2.05M | ﹤0.01% |
146,665
-28,100
| -16% | -$260K |
|
2172
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $2.04M | ﹤0.01% |
20,100
+9,200
| +84% | +$887K |
|
2173
Superior Group of Companies
SGC
$208M
| $2.04M | ﹤0.01% |
152,410
-36,900
| -19% | -$350K |
|
2174
National Bankshares
NKSH
$270M
| $2.04M | ﹤0.01% |
71,270
-8,900
| -11% | -$259K |
|
2175
Champions Oncology
CSBR
$70.4M
| $2.04M | ﹤0.01% |
212,946
+35,900
| +20% | +$306K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.